Matinas BioPharma | Investor Presentation Deck | 31 slides · page 16 of 31
The chart uses a vertical dotted line at 0.2 to denote a clinical efficacy threshold.
Pitch deck · peer_benchmark · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 disclaimer 1/1 source-note 1/1 title 1/1
Components 5
primary dot disclaimer source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1